🇺🇸 FDA
Pipeline program

Placebo of Eliquis 2.5 mg, Eliquis 2.5 mg film-coated tablets

P170916J

Phase 3 small_molecule active

Quick answer

Placebo of Eliquis 2.5 mg, Eliquis 2.5 mg film-coated tablets for Intrahepatic non-cirrhotic portal hypertension is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Intrahepatic non-cirrhotic portal hypertension
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials